Literature DB >> 19880910

Late admission to the ICU in patients with community-acquired pneumonia is associated with higher mortality.

Marcos I Restrepo1, Eric M Mortensen, Jordi Rello, Jennifer Brody, Antonio Anzueto.   

Abstract

BACKGROUND: Limited data are available on the impact of time to ICU admission and outcomes for patients with severe community acquired pneumonia (CAP). Our objective was to examine the association of time to ICU admission and 30-day mortality in patients with severe CAP.
METHODS: A retrospective cohort study of 161 ICU subjects with CAP (by International Classification of Diseases, 9th edition, codes) was conducted over a 3-year period at two tertiary teaching hospitals. Timing of the ICU admission was dichotomized into early ICU admission (EICUA, direct admission or within 24 h) and late ICU admission (LICUA, >or= day 2). A multivariable analysis using Cox proportional hazard model was created with the primary outcome of 30-day mortality (dependent measure) and the American Thoracic Society (ATS) severity adjustment criteria and time to ICU admission as the independent measures.
RESULTS: Eighty-eight percent (n = 142) were EICUA patients compared with 12% (n = 19) LICUA patients. Groups were similar with respect to age, gender, comorbidities, clinical parameters, CAP-related process of care measures, and need for mechanical ventilation. LICUA patients had lower rates of ATS severity criteria at presentation (26.3% vs 53.5%; P = .03). LICUA patients (47.4%) had a higher 30-day mortality compared with EICUA (23.2%) patients (P = .02), which remained after adjusting in the multivariable analysis (hazard ratio 2.6; 95% CI, 1.2-5.5; P = .02).
CONCLUSION: Patients with severe CAP with a late ICU admission have increased 30-day mortality after adjustment for illness severity. Further research should evaluate the risk factors associated and their impact on clinical outcomes in patients admitted late to the ICU.

Entities:  

Mesh:

Year:  2009        PMID: 19880910      PMCID: PMC3021366          DOI: 10.1378/chest.09-1547

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  27 in total

1.  Severity prediction rules in community acquired pneumonia: a validation study.

Authors:  W S Lim; S Lewis; J T Macfarlane
Journal:  Thorax       Date:  2000-03       Impact factor: 9.139

2.  Associations between empirical antimicrobial therapy at the hospital and mortality in patients with severe community-acquired pneumonia.

Authors:  J Rello; M Catalán; E Díaz; M Bodí; B Alvarez
Journal:  Intensive Care Med       Date:  2002-04-25       Impact factor: 17.440

3.  Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study.

Authors:  W S Lim; M M van der Eerden; R Laing; W G Boersma; N Karalus; G I Town; S A Lewis; J T Macfarlane
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

4.  Severity of pneumococcal pneumonia associated with genomic bacterial load.

Authors:  Jordi Rello; Thiago Lisboa; Manel Lujan; Miguel Gallego; Cordelia Kee; Ian Kay; Diego Lopez; Grant W Waterer
Journal:  Chest       Date:  2009-05-11       Impact factor: 9.410

5.  Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study.

Authors:  Eric M Mortensen; Christopher M Coley; Daniel E Singer; Thomas J Marrie; D Scott Obrosky; Wishwa N Kapoor; Michael J Fine
Journal:  Arch Intern Med       Date:  2002-05-13

6.  Severe community-acquired pneumonia. Etiology, epidemiology, and prognosis factors. French Study Group for Community-Acquired Pneumonia in the Intensive Care Unit.

Authors:  P Moine; J B Vercken; S Chevret; C Chastang; P Gajdos
Journal:  Chest       Date:  1994-05       Impact factor: 9.410

7.  Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria.

Authors:  Derek C Angus; Thomas J Marrie; D Scott Obrosky; Gilles Clermont; Tony T Dremsizov; Christopher Coley; Michael J Fine; Daniel E Singer; Wishwa N Kapoor
Journal:  Am J Respir Crit Care Med       Date:  2002-09-01       Impact factor: 21.405

8.  Validation of predictive rules and indices of severity for community acquired pneumonia.

Authors:  S Ewig; A de Roux; T Bauer; E García; J Mensa; M Niederman; A Torres
Journal:  Thorax       Date:  2004-05       Impact factor: 9.139

9.  Severe community-acquired pneumonia. Epidemiology and prognostic factors.

Authors:  A Torres; J Serra-Batlles; A Ferrer; P Jiménez; R Celis; E Cobo; R Rodriguez-Roisin
Journal:  Am Rev Respir Dis       Date:  1991-08

10.  A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit.

Authors:  O Leroy; C Santré; C Beuscart; H Georges; B Guery; J M Jacquier; G Beaucaire
Journal:  Intensive Care Med       Date:  1995-01       Impact factor: 17.440

View more
  56 in total

Review 1.  [Severe community-acquired and hospital-acquired pneumonia].

Authors:  L Witte; D Drömann
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-03-11       Impact factor: 0.840

2.  Severe Pneumococcal Pneumonia Causes Acute Cardiac Toxicity and Subsequent Cardiac Remodeling.

Authors:  Luis F Reyes; Marcos I Restrepo; Cecilia A Hinojosa; Nilam J Soni; Antonio Anzueto; Bettina L Babu; Norberto Gonzalez-Juarbe; Alejandro H Rodriguez; Alejandro Jimenez; James D Chalmers; Stefano Aliberti; Oriol Sibila; Vicki T Winter; Jacqueline J Coalson; Luis D Giavedoni; Charles S Dela Cruz; Grant W Waterer; Martin Witzenrath; Norbert Suttorp; Peter H Dube; Carlos J Orihuela
Journal:  Am J Respir Crit Care Med       Date:  2017-09-01       Impact factor: 21.405

Review 3.  Update in pulmonary infections 2010.

Authors:  Richard G Wunderink; Grant W Waterer
Journal:  Am J Respir Crit Care Med       Date:  2011-07-15       Impact factor: 21.405

4.  Determination of neutrophil CD64 expression as a prognostic biomarker in patients with community-acquired pneumonia.

Authors:  J Burgos; I Los-Arcos; D Álvarez de la Sierra; V Falcó; A Aguiló; I Sánchez; B Almirante; M Martinez-Gallo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-05-30       Impact factor: 3.267

5.  Relationships among initial hospital triage, disease progression and mortality in community-acquired pneumonia.

Authors:  Samuel M Brown; Jason P Jones; Dominik Aronsky; Barbara E Jones; Michael J Lanspa; Nathan C Dean
Journal:  Respirology       Date:  2012-11       Impact factor: 6.424

6.  Differences in hospital- and ventilator-associated pneumonia due to Staphylococcus aureus (methicillin-susceptible and methicillin-resistant) between Europe and Latin America: a comparison of the EUVAP and LATINVAP study cohorts.

Authors:  J Rello; D Molano; M Villabon; R Reina; R Rita-Quispe; I Previgliano; E Afonso; M I Restrepo
Journal:  Med Intensiva       Date:  2012-06-28       Impact factor: 2.491

7.  Association of Intensive Care Unit Admission With Mortality Among Older Patients With Pneumonia.

Authors:  Thomas S Valley; Michael W Sjoding; Andrew M Ryan; Theodore J Iwashyna; Colin R Cooke
Journal:  JAMA       Date:  2015 Sep 22-29       Impact factor: 56.272

8.  Managing CAP in the ICU.

Authors:  Liapikou Adamantia; Makrodimitri Sotiria; Melaxroinidou Myrsini; Toumbis Michael
Journal:  Curr Infect Dis Rep       Date:  2015-11       Impact factor: 3.725

Review 9.  Defining severe pneumonia.

Authors:  Samuel M Brown; Nathan C Dean
Journal:  Clin Chest Med       Date:  2011-07-12       Impact factor: 2.878

10.  Is N-terminal pro-B-type natriuretic peptide ready for 'prime time' in severe pneumonia?

Authors:  Juan Felipe Fernandez; Marcos I Restrepo
Journal:  Respirology       Date:  2013-08       Impact factor: 6.424

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.